An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor

摘要

This case report presents the response to experimental drug gilteritinib hemifumarate in a patient with ophthalmological complications of relapsed acute myeloid leukemia with FMS-like tyrosine kinase 3 (FLT3) gene mutation.